Sec Form 5 Filing - WITHROW EDWARD W III @ PARALLAX HEALTH SCIENCES, INC. - 2021-12-31

FORM 5 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person WITHROW EDWARD W III 2. Issuer Name and Ticker or Trading Symbol PARALLAX HEALTH SCIENCES, INC. [ PRLX] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 3415 S SEPULVEDA BLVD, SUITE 1100-1234 3. Date of Earliest Transaction (MM/DD/YY) 12/31/2021 (Street) LOS ANGELES, CA90034 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price PREFERRED STOCK (SERIES A) 09/30/2011( 1 ) J( 1 ) V 36,339 A $ 2.75 399,732 I By Huntington Chase Financial Group PREFERRED STOCK (SERIES A) 11/06/2021 J( 2 ) V 396,339 A $ 0 796,071 I By Huntington Chase Financial Group PREFERRED STOCK (SERIES A) 11/06/2021 J( 3 ) V 796,071 D $ 0 0 I By Huntington Chase Financial Group COMMON STOCK 11/06/2021 J( 3 ) V 15,921,420( 3 ) A $ 0 72,430,792 I By Huntington Chase LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Benefi cially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares STOCK OPTION $ 0.25 03/31/2021 D V 3,000,000( 4 ) ( 4 ) 12/31/2022 COMMON STOCK 3,000,000 $ 0 1,000,000 I By Huntington Chase LLC

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other WITHROW EDWARD W III 3415 S SEPULVEDA BLVD SUITE 1100-1234 LOS ANGELES, CA90034 X Signatures EDWARD W. WITHROW III 03/17/2022 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Additional Series A Preferred shares acquired; not included in previous Form 5 for the year 12/31/2012. Total Series A Preferred shares held at 12/31/12 = 399,732. ( 2 )Cumulative dividends in kind on Series A Preferred Stock. ( 3 )Conversion of preferred stock into common stock at a ratio of 20 shares of common stock for each share of preferred stock. ( 4 )Unvested stock options canceled upon resignation of Reporting Person.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.